Clinic
County of Los Angeles
County of Los Angeles was paid $47K by Medicaid between Feb 2019 and Nov 2024, across 41 billing codes. Its largest line is G9008, Coordinated care fee, physician coordinated care oversight services — 98% of everything it billed.
33Billing provider infoCOUNTY OF LOS ANGELES
CHATSWORTH, CA 91311
CHATSWORTH, CA 91311
33aNPI1275067795assigned 04/12/2017
33bProvider typeClinic/Center
28Total paid$47K
24GClaims21,625
24DCodes billed41
24AFirst – last monthFeb 2019 – Nov 2024
Compared with peers
Next to other Clinic/Center providers in California
Rank by total paid#306 of 504
Median peer was paid$102K
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official O'BRIEN, QUENTIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 709 | $0.00 | |
| 2020 | 1,964 | $0.00 | |
| 2021 | 3,902 | $0.00 | |
| 2022 | 4,597 | $21K | |
| 2023 | 5,142 | $18K | |
| 2024incomplete | 5,311 | $8K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G9008 | Coordinated care fee, physician coordinated care oversight services | 98% | 1,301 | 1,023 | $46K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.5% | 1,272 | 1,241 | $708.48 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 322 | 313 | $88.33 |
| 86703 | <1% | 612 | 608 | $36.03 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 825 | 820 | $17.78 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,520 | 1,261 | $9.50 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,589 | 1,576 | $6.12 |
| 80061 | Lipid panel | <1% | 1,446 | 1,435 | $5.77 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,659 | 1,535 | $4.84 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,116 | 1,069 | $3.63 |
| 80076 | <1% | 638 | 636 | $3.19 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 21 | 12 | $0.00 |
29 more codes
| 82274 | 0% | 110 | $0.00 | |
| 3078F | 0% | 441 | $0.00 | |
| 99442 | 0% | 1,353 | $0.00 | |
| 82540 | 0% | 89 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 45 | $0.00 |
| 86705 | 0% | 55 | $0.00 | |
| 84439 | 0% | 27 | $0.00 | |
| 3077F | 0% | 19 | $0.00 | |
| 87340 | 0% | 414 | $0.00 | |
| 36415 | Collection of venous blood by venipuncture | 0% | 3,268 | $0.00 |
| 87522 | Neg quan hep c or qual rna | 0% | 524 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 1,021 | $0.00 |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 244 | $0.00 |
| 3074F | 0% | 375 | $0.00 | |
| 85027 | 0% | 100 | $0.00 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 256 | $0.00 |
| 3044F | 0% | 166 | $0.00 | |
| 86706 | 0% | 117 | $0.00 | |
| 3075F | 0% | 60 | $0.00 | |
| 83735 | 0% | 17 | $0.00 | |
| 1220F | 0% | 77 | $0.00 | |
| 82043 | 0% | 89 | $0.00 | |
| 1111F | 0% | 164 | $0.00 | |
| 99441 | 0% | 100 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 0% | 46 | $0.00 |
| 4450F | 0% | 26 | $0.00 | |
| 3079F | 0% | 45 | $0.00 | |
| 81001 | 0% | 13 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 43 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialO'BRIEN, QUENTIN (ACN, CEO)
| Provider | Location | Paid |
|---|---|---|
| County of Los Angeles | El Monte, CA | $3.55M |
| County of Los Angeles | Lancaster, CA | $445K |
| County of Los Angeles | Los Angeles, CA | $428K |
| County of Los Angeles | San Fernando, CA | $408K |
| County of Los Angeles | Los Angeles, CA | $346K |
| County of Los Angeles | Los Angeles, CA | $323K |
| County of Los Angeles | Los Angeles, CA | $284K |
| County of Los Angeles | El Monte, CA | $259K |
| County of Los Angeles | Los Angeles, CA | $249K |
| County of Los Angeles | Van Nuys, CA | $144K |
| County of Los Angeles | Long Beach, CA | $78K |
| County of Los Angeles | La Puente, CA | $77K |
| County of Los Angeles | Palmdale, CA | $65K |
| County of Los Angeles | Lancaster, CA | $57K |
| County of Los Angeles | Torrance, CA | $42K |
| County of Los Angeles | Inglewood, CA | $40K |
| County of Los Angeles | Bellflower, CA | $33K |
| County of Los Angeles | Glendale, CA | $24K |
| County of Los Angeles | Wilmington, CA | $19K |
| County of Los Angeles | Los Angeles, CA | $15K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.